Member Info for ace2326

When is the vote guys? I am absolutely voting

£5.7m / 52m shares = 11p

Why agree to sell at £2.375m the core business when that’s not remotely what your share holders would like.

The margins are obscured, and the phlebotomy is announced then suddenly the core of the company is taken away from shareholders on the cheap.

All the lack of news flow, the non existent marketing, non existent effort to create new sales avenues or show any care surrounding share price for the investor now all completely makes sense.

This is morally appalling how this is all panning out. My issue isn’t so much with the buyer it’s with those with the reigns. This will no doubt have had champagne and celebrations over, with zero sleep lost what impact this action has had on hundreds, maybe thousands of investors.

So what happens if we hold our shares?

What happens if the vote is no? (To sale)

Is there any logic in averaging down here?

Wes you Obv didn’t listen attend or see the last investor presentation.

Penny said we won’t be wasting money on adverts, Google ads or marketing as she thinks it will just evaporate the pot.

Kinda get it, kinda don’t, one things for sure it’s not our jobs to. I’m getting increasingly fed up with this share serving zero investor value.

Jam Rock you keep saying £7.6m like the accounts have stood still for 6 months or whatever. (Yes that’s how much time is passing with the share price now at 1p)

I don’t want a dividend. It might be a reward for yourself with a bazillion shares. I’d even get a 4 figure return myself from one. But like the consolidation, or any of the faffing about we’ve done in the last few years it’s a plaster over an amputation.

We need far more regular updates, PR, marketing, more of those non exclusive partnership deals, proof the business works.

We need 40-50p a lot of us. Far far greater than £XXX for most, £XXXX for me, and probably £XX,XXX for you.

I don’t want the company to dip into whatever is left of that £7.6m to pay us out, so we can reinvest and average down. How about just focus on investor value.

As of now there literally isn’t any. It’s that simple

Bottom looking more like 16-17p, it’s not uncommon to see directors not actively buying on the reg, people have lives to lead. Think this share needs time, and also to prove itself with non Cov sales, and more “non exclusive” business with the tests.

Also think the overall bigger picture with regards to the economy is a factor. We aren’t pulling up trees and we are definitely one of the more financially sound AIM stocks out there. It will be a patient wait needed to see this push north of 50p now really alongside a less bearish sentiment in the market overall required.

Sorry posted without the rest of the message.

I don’t think we will be buying yourgene. We have less than 20 employees. I can’t see us taking on something like that right now and bloating the company and detracting from our main focus, without any guaranteed income beyond covid for now. Let alone adding something that would inevitably churn away at our pot of cash.

We won’t be buying Yourgene

We have

Hate to be a flatulent fart cushion but Zak Mir trading has been wrong for the last 2 years I’ve heard about it. Roll on 40p that’s my AVG

My math is 18p too. I don’t think it’s a priority right now. The priority is getting the product released and marketed. We seem to be doing everything and anything else other than that. Meanwhile just seen below Tesco now a competitor. Why were we not on it to be their point of outsource?

The consolidation is good in the sense it moves us out of the penny share stigma. But in the event the business takes a poor turn, should we ever see a placing on top there after our shares are worth less than they are now.

The question I have, is the share buy back we got an RNS about. It was like 50-70m shares. Will this get shrunk by 15x, or could the company in theory buy all remaining 52m shares if the price was right?

My biggest question unless I zoned out and missed it in the presentation replay, is why was this not mentioned once?

Expecting to hear this sort of thing moving forward. As said previously, this market will not wait around for MHC to get their ducks in order.

Fiddling around with consolidation and share buy backs starting to sound a bit like TLSA. Lots of rearranging the furniture, but not addressing a hole in the wall.

Jam, I broke my @rse off to rally scrimp and save to get my £27k together for this. As you know the cost of living has gone up, and with that the economy isn’t in a great position.

Unfortunately we aren’t all in a position to AVG down atm.

Trust me if I had £10k right now, I’d have bought at 1p to get my AVG to 1.8p, hence knowing the math off the top of my head, I did it as an exercise frustratingly last night.

I don’t think the business is in disarray far from it, I’d love to double my shares to 2m, and I’d have faith in doing so.

But it’s not as easy for some of us to keep adding the way you do.

I appreciate your commitment and appetite for MHC. I wish I could join you but not able to atm. Hence the frustration being over 50% down, after a year and a half of already avg down and trying to bail out the stocks poor performance

Jam, you have said it will move higher in the short term for the last year. We are at or around 1.70-1.80p when you said that. The medium term has passed and it’s 1p.

Let’s start calling spades spades, and if something walks talks and looks like a duck it’s a duck.

This looks like a 3p share, and we know exactly why it’s a 1p share. Can we stop pretending it’s going to be 3p in the short term. The BOD are accountable for delivering everything mentioned in the presentation. Same way they were since the “soft launch”. The can was kicked down the road and is now being rebranded as not really launched properly yet, rather than launched poorly.

If they weren’t launched officially, we wouldn’t have got big elaborate RNS about it being a milestone, followed by an amateurish series of Amazon listings trying something other than hammering the mailing list to sell them.

Penny kept repeating the mantra of investor value. If 98% of us sold the share tomorrow, 100% of us would find our money devalued.

There’s no value in that. They’ve had a full year, and are still going on about creating B2B2C deals, releasing new products and preparing to sell them.

Get on with it, the wellness market is carrying on without us and not waiting around. Every day that passes is a day where potential customers are getting their tests elsewhere and likely not buying another one to be retold the same information.

Chop chop.

Hotchip sorry but that is total tosh.

TLSA (who aren’t even a good advertisement for communications or healthy share price) have released a feed of news that has taken them from $.60 over $1

Their input directly effected the share price, which was necessary to keep them on the Nasdaq.

So to say a board can’t impact the share price is tosh.

More news and progress and transparency please

Can someone ask the simple question later in the investor meet, how many of the wellness tests we have sold. I can’t believe nearly a year of RNS has now passed with near radio silence. And as an investor I still have yet to be told explicitly how many have been sold.

Wouldn’t you think they’d share how many we’ve sold by now in one rns since last summer if there was a milestone number to mention

Wouldn’t you think they’d share how many we’ve sold by now in one rns since last summer if there was a milestone number to mention re wellness tests

Better less shares, means yours are worth more

Another RNS that has avoided specifically addressing exactly how many wellness tests have been sold

Signed up. Here’s mine. Hoping we can all paste what we added. So if the same subjects crop up, we know the general gist of what was asked and what’s been avoided.

Question 1:
What are you going to do about the share price to bring value to the shareholder?
Question 2:
Why are the new products late and why have you not apologised or provided any explanation to the market about that?
Question 3:
Why is there no marketing and sales strategy for the wellness products?
Question 4:
What will be different in regards to the release of the next line of products, to the first batch which you clearly haven’t managed to sell well?